NLRP3 and injury: This is consistent with findings from previous literature showing that the inhibition of XBP1 activity reduced NLRP3 inflammasome assembly and caspase-1 processing in a model of hepatic ischemia-reperfusion, thus reducing IRI-triggered liver injury [33, 34].